Teva Pharmaceutical (TEVA) amends Rule 144; 447,778 shares listed with Citigroup

Rhea-AI Filing Summary

Teva Pharmaceutical Industries Limited filed an amendment to a Rule 144 notice that lists proposed disposition of 447,778 ordinary shares through Citigroup Global Markets. The amendment also lists 161,656 restricted share units and 620,110 performance share units, each dated 02/15/2023, with an entry date of 02/17/2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ORDINARY SHARES	CITIGROUP GLOBAL MARKETS 390 GREENWICH ST NEW YORK NY 10013	447778	15324798.00	1149812898	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	02/15/2023	RESTRICTED SHARE UNIT AWARD	TEVA PHARMACEUTICAL INDUSTRIES LIMITED			161656	02/17/2026	COMPENSATION
ORDINARY SHARES	02/15/2023	PERFORMANCE SHARE UNIT AWARD	TEVA PHARMACEUTICAL INDUSTRIES LIMITED			620110	02/17/2026	COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does TEVA's Form 144/A list as the security and quantity?

The filing lists ordinary shares and specifies 447,778 shares slated in the amendment. It identifies Citigroup Global Markets as the broker and includes related equity awards dated 02/15/2023.

Does the 144/A show equity awards tied to the TEVA shares?

Yes. The amendment records 161,656 restricted share units and 620,110 performance share units, both dated 02/15/2023. Those award counts are included in the filing's security lines.

Which broker-dealer is named in the TEVA 144/A amendment?

The filing names Citigroup Global Markets at 390 Greenwich Street, New York, NY, as the broker-dealer associated with the listed ordinary shares. That broker appears alongside the 447,778 shares line.

What dates are shown in the TEVA 144/A amendment?

The document shows award grant dates of 02/15/2023 for the RSUs and PSUs and an entry or filing date of 02/17/2026. Those dates appear in the security and award lines.

Does the amendment state how proceeds will be used or received?

The excerpt does not state the use of proceeds or who will receive sale proceeds. The amendment lists security quantities, award types, broker name, and dates but contains no proceeds allocation language.